The promise of new anti-obesity therapies is arising from knowledge of genetic obesity traits. By studying the genes of people with obesity, researchers are learning how different genes contribute to the development of obesity. This knowledge is leading to the development of new therapies that target the specific genes involved in obesity.
One such therapy is a drug that targets the gene FTO. FTO is a gene that has been linked to obesity. The drug works by inhibiting the activity of FTO, which leads to weight loss.
Another therapy under development is a vaccine that targets the gene leptin. Leptin is a hormone that regulates appetite. The vaccine works by increasing the levels of leptin in the body, which leads to reduced appetite and weight loss.
These are just two of the many new therapies that are under development for the treatment of obesity. With continued research, even more effective therapies are sure to be developed. This is good news for the millions of people who suffer from obesity.